Portfolio

We are developing the first oral FcRn inhibitors.

Membrane Receptor

FcRn

Orthosteric Modulator

Enablement

Hit Finding

Hit-to-Lead

Lead Optimization

IND Enabling

Lead Optimization

Membrane Receptor

FcRn

Orthosteric Modulator

Enablement

Hit Finding

Hit-to-Lead

Lead Optimization

IND Enabling

Lead Optimization

Membrane Receptor

FcRn

Allosteric Modulator

Enablement

Hit Finding

Hit-to-Lead

Lead Optimization

IND Enabling

Hit-to-Lead

Multiple additional targets across the membranome, secretome, and intracellular proteome enabled for hit finding through internal capabilities. If interested in collaborating on areas of discovery, please reach out.